Insilico CEO Zhavoronkov on AI Anti-Aging

Insilico Medicine CEO Alex Zhavoronkov, PhD, was featured in an exclusive interview with Fox Business, discussing the potential of artificial intelligence to slow aging.

As the leader of an AI-driven drug discovery company, Zhavoronkov's perspective offers a professional view on AI applications at the frontier of life sciences. This video is recommended for readers interested in AI healthcare and anti-aging research.